StonvexLoading…
StonvexStonvexStonvexCore line items from RAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Annual 2025 2025-12-31 | Q3 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $534.60M | $2.07B | $1.51B | $985.10M |
Operating Income | $68.10M | $-1.18B | $184.80M | $132.70M |
Net Income | $44.20M | $-1.22B | $151.40M | $47.60M |
EPS (Diluted) | $0.39 | $-10.84 | $1.34 | $0.99 |
Total Assets | $3.70B | $3.82B | $5.27B | $5.18B |
Total Liabilities | $2.13B | $2.19B | Not available | Not available |
Cash & Equivalents | $268.00M | $318.80M | $264.20M | $198.60M |
Free Cash Flow OCF − CapEx | $10.40M | $358.40M | $266.80M | $140.20M |
Shares Outstanding | 111.90M | 112.90M | 112.80M | 112.70M |